Skip to main content
TED Radio Hour

Rethinking addiction in the age of Ozempic

50 min episode · 2 min read
·
Dhruv Kullar

Episode

50 min

Read time

2 min

Topics

Health & Wellness, Software Development, Psychology & Behavior

AI-Generated Summary

Key Takeaways

  • GLP-1 Cross-Addiction Mechanism: Semaglutide appears to reduce cravings across multiple substance categories simultaneously — alcohol, nicotine, opioids, and cocaine — by limiting dopamine spikes in the brain's mesolimbic reward pathway. Unlike existing addiction medications, which target specific substances separately, GLP-1s may address a universal addiction pathway, representing the first genuinely cross-addiction pharmacological tool.
  • Anhedonia Risk in GLP-1 Treatment: A documented side effect of GLP-1 medications is emotional blunting, where users lose interest not just in addictive substances but in pleasurable activities generally. Clinicians should screen patients for anhedonia symptoms during treatment. Additionally, over 50% of patients discontinue these medications within 12 months, limiting long-term efficacy regardless of initial response.
  • Cost and Access Barrier: GLP-1 medications currently carry a sticker price of $1,000–$1,300 per month without insurance coverage, creating a significant equity gap in addiction treatment access. Clinicians and advocates should actively pursue insurance authorization and manufacturer assistance programs, as cost remains the primary structural barrier preventing broader adoption in addiction medicine.
  • Trauma as Addiction Driver: The Adverse Childhood Experiences (ACE) test score correlates directly with addiction likelihood — higher scores predict significantly greater risk. Effective recovery programs should incorporate trauma processing alongside biological interventions. Behavioral coach Eric Zimmer, 30 years in recovery from heroin, identifies unresolved trauma as a central mechanism sustaining addiction cycles beyond substance dependence itself.
  • Self-Compassion as Recovery Skill: Shame and guilt actively worsen addiction by triggering the same discomfort that drives substance use, creating a downward spiral. Zimmer's coaching framework reframes failed behavior-change attempts as skill gaps rather than character flaws. Motivation measurably increases when individuals maintain positive self-perception, making self-compassion a functional, learnable tool rather than optional emotional support.

What It Covers

TED Radio Hour examines GLP-1 drugs like Ozempic as potential addiction treatments, exploring how these medications may suppress cravings across alcohol, opioids, and nicotine by modulating the brain's dopamine reward pathway, while behavioral coach Eric Zimmer argues recovery requires a multi-component approach beyond any single pharmaceutical solution.

Key Questions Answered

  • GLP-1 Cross-Addiction Mechanism: Semaglutide appears to reduce cravings across multiple substance categories simultaneously — alcohol, nicotine, opioids, and cocaine — by limiting dopamine spikes in the brain's mesolimbic reward pathway. Unlike existing addiction medications, which target specific substances separately, GLP-1s may address a universal addiction pathway, representing the first genuinely cross-addiction pharmacological tool.
  • Anhedonia Risk in GLP-1 Treatment: A documented side effect of GLP-1 medications is emotional blunting, where users lose interest not just in addictive substances but in pleasurable activities generally. Clinicians should screen patients for anhedonia symptoms during treatment. Additionally, over 50% of patients discontinue these medications within 12 months, limiting long-term efficacy regardless of initial response.
  • Cost and Access Barrier: GLP-1 medications currently carry a sticker price of $1,000–$1,300 per month without insurance coverage, creating a significant equity gap in addiction treatment access. Clinicians and advocates should actively pursue insurance authorization and manufacturer assistance programs, as cost remains the primary structural barrier preventing broader adoption in addiction medicine.
  • Trauma as Addiction Driver: The Adverse Childhood Experiences (ACE) test score correlates directly with addiction likelihood — higher scores predict significantly greater risk. Effective recovery programs should incorporate trauma processing alongside biological interventions. Behavioral coach Eric Zimmer, 30 years in recovery from heroin, identifies unresolved trauma as a central mechanism sustaining addiction cycles beyond substance dependence itself.
  • Self-Compassion as Recovery Skill: Shame and guilt actively worsen addiction by triggering the same discomfort that drives substance use, creating a downward spiral. Zimmer's coaching framework reframes failed behavior-change attempts as skill gaps rather than character flaws. Motivation measurably increases when individuals maintain positive self-perception, making self-compassion a functional, learnable tool rather than optional emotional support.

Notable Moment

A physician underwent an MRI scan while viewing images of alcohol and food. His brain showed minimal activity in reward centers. When researchers showed identical images to people with alcohol use disorder, those same brain regions lit up intensely — visually demonstrating that addiction responses occur before conscious decision-making even begins.

Know someone who'd find this useful?

Episode Transcript

This message comes from Great Wolf Lodge. There's adventure for the whole family, including an indoor water park that's always 84 degrees, attractions, spacious suites, and more. You're just a short drive away from an unforgettable family getaway. Learn more at greatwolf.com. This is the TED Radio Hour. Each week, groundbreaking TED Talks Our job now is to dream big. Delivered at TED conferences To bring about the future we want to see. Around the world. To understand who we are. From those talks, we bring you speakers and ideas that will surprise you. You just don't know what you're gonna find. Challenge you. We truly have to ask ourselves, like, why is it noteworthy? And even change you. I literally feel like I'm a different person. Yes. Do you feel that way? Moderation is is is so important. There are so many things in life that we want a little of, maybe, quite a bit of, but not too much of. And, you know, Aristotle obviously had this insight many centuries ago. This is Dhruv Kullar. He is a physician at Weill Cornell Medical College, and he would love his patients to live by Aristotle's famous words. It is best to rise from life as from a banquet, neither thirsty nor drunken. But in the modern era Our world is kind of designed for too much these days. It's just inundated with content and food and desire and all sorts of things. For some people, just having access to all these earthly delights makes moderation impossible. Take a woman named Mary, for for example. I met Mary last year. She's a middle aged woman, and she has been struggling with alcohol addiction for decades. She told me that she started drinking when she was 18 years old, and soon after, she could drink something like 18 beers in the sitting and and barely even seem buzzed. And Mary tried all sorts of things to try to cut back on her drinking. She entered Alcoholics Anonymous. She used a medication called Antabuse. She tried alcohol rehab, but none of them were effective. And she struggled with alcohol, and it started to really take a toll on many aspects of her life. Then about a year ago, she was at a bar with a friend who usually also liked to drink a lot. But that evening, Mary noticed that her friend had barely touched her drink. And her friend told her that she started taking Ozempic, and now she could barely bring herself to drink more than two beers at a time. And Mary was really interested in this. She'd always thought of Ozempic as kind of a obesity medicine or a diabetes medicine, and she was wondering, you know, what what did it have to do with drinking? And as it happened, the next day, she saw this advertisement on Facebook that there was a clinical trial nearby that was studying whether Ozempic or semaglutide could help people with alcohol …

Get the full transcript (9,038 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all TED Radio Hour transcripts →

You just read a 3-minute summary of a 47-minute episode.

Get TED Radio Hour summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

Books, tools, and gear mentioned in this episode

SignalCast may earn commission on purchases via these links.

Tools

More from TED Radio Hour

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best Science Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into TED Radio Hour.

Every Monday, we deliver AI summaries of the latest episodes from TED Radio Hour and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime